29.04.2015 • NewsDede WillamsMillikenSilane

SiVance Opens Lab for Silane and Silicone Technologies

Belgium's SiVance, a subsidiary of Milliken & Company, has opened a new research and development laboratory at its R&D and manufacturing campus in Gainesville, Florida.

SiVance said the new center, part of a planned series of investments targeting current and future customer needs in markets such as electronic semiconductors, contact lenses, coatings and light-emitting diodes (LEDs) will enhance its ability to quickly develop and scale new silane and silicone technologies.

The lab is also planned to speed process development for custom manufacturing of specialty silanes, silicones and other chemistries.

"This state-of-the-art facility is a major milestone in our continuous investment strategy for the business, which was initiated following Milliken's acquisition of SiVance in 2011," said SiVance vice president, Saikat Joardar.

Joardar said the new lab will accelerate product and process development and scale up to manufacturing, strengthen collaboration with customers while taking advantage of new market opportunities for chemistries that fit the company's expertise and capabilities.

Whitepaper

Excellence in Pharmaceutical Distribution and The Critical Role of Good Distribution Practice (GDP)
Setting the Standard

Excellence in Pharmaceutical Distribution and The Critical Role of Good Distribution Practice (GDP)

Are you ready to elevate your pharmaceutical operations? Download our exclusive whitepaper and discover how compliance with Good Distribution Practice (GDP) is essential for the safety and integrity of pharmaceuticals.

Virtual Event

Digitalization in the Chemical Industry
CHEManager Spotlight

Digitalization in the Chemical Industry

Save the Date: October 22, 2025
The event will be promoted to a combined audience of over 100,000 professionals across Europe through the CHEManager and CITplus networks.

most read

Photo
28.07.2025 • NewsChemistry

VCI Welcomes US-EU Customs Deal

The German Chemical Industry Association (VCI) welcomes the fact that Ursula von der Leyen, President of the European Commission, and US President Donald Trump have averted the danger of a trade war for the time being.

Photo
13.03.2025 • News

Roche and Zealand Pharma Collaborate on Weight Management Drug

Swiss pharma heavyweight Roche announced has entered into an exclusive collaboration and licensing agreement with Denmark’s Zealand Pharma. Under the terms of this agreement, the two companies will collaborate to co-develop and co-commercialize petrelintide, Zealand Pharma’s amylin analog as a standalone therapy as well as a fixed-dose combination with Roche’s lead incretin asset CT-388.